Sign in

CIK 0001621227

  • Non-accelerated filer
  • Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1235430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-20 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +5,143,248 5,143,248
2025-02-20 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +3,428,832 3,428,832
2025-01-17 Rawcliffe Adrian Chief Executive Officer Sale −30,601 $0.58 $18K 44,327
2025-01-15 Rawcliffe Adrian Chief Executive Officer Sale −29,096 $0.57 $17K 41,582
2025-01-13 Rawcliffe Adrian Chief Executive Officer Sale −12,539 $0.59 $7K 17,801
2025-01-13 Rawcliffe Adrian Chief Executive Officer Sale −17,934 $0.59 $11K 25,711
2024-01-17 Rawcliffe Adrian Chief Executive Officer Sale −30,080 $0.67 $20K 44,848
2024-01-16 Rawcliffe Adrian Chief Executive Officer Sale −9,304 $0.79 $7K 14,104
2024-01-15 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +7,633,296 7,633,296
2024-01-15 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +1,696,272 1,696,272
2024-01-12 Rawcliffe Adrian Chief Executive Officer Sale −17,257 $0.85 $15K 26,388
2024-01-11 Rawcliffe Adrian Chief Executive Officer Sale −11,945 $0.84 $10K 18,395
2023-09-01 Rawcliffe Adrian Chief Executive Officer Sale −2,403 $0.78 $2K 3,449
2023-06-27 Rawcliffe Adrian Chief Executive Officer Sale −2,333 $0.92 $2K 3,519
2023-01-17 Rawcliffe Adrian Chief Executive Officer Sale −10,057 $1.86 $19K 13,351
2023-01-17 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +4,690,224 4,690,224
2023-01-17 Rawcliffe Adrian Chief Executive Officer Grant or award · Option to purchase Ordinary Shares +1,798,272 1,798,272
2023-01-12 Rawcliffe Adrian Chief Executive Officer Sale −18,763 $1.71 $32K 24,882
2023-01-11 Rawcliffe Adrian Chief Executive Officer Sale −13,042 $1.75 $23K 17,298
2023-01-04 Rawcliffe Adrian Chief Executive Officer Sale −5,073 $1.69 $9K 6,631

Page 1 of 3 · 53 trades